Anthony W Tolcher

Novel therapeutic molecular targets for prostate cancer: the mTOR signaling pathway and epidermal growth factor receptor.

A. Tolcher, Anthony W Tolcher, 2004, The Journal of urology.

A Phase I and pharmacokinetic study of squalamine, an aminosterol angiogenesis inhibitor.

A. Tolcher, C. Takimoto, A. Patnaik, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors

Lon Smith, Omar Laterza, Robert H Pierce, 2015, Clinical Cancer Research.

Improving combination cancer therapy: the CombiPlex® development platform.

A. Tolcher, L. Mayer, Lawrence D Mayer, 2018, Future oncology.

Safety and Activity of the First-in-Class Sym004 Anti-EGFR Antibody Mixture in Patients with Refractory Colorectal Cancer.

Rodrigo Dienstmann, Josep Tabernero, B. Tops, 2015, Cancer discovery.